Disability Resource Directory

View Original Article Tue, 08 Jul 2008 15:00:00 PDT
Using mouse embryonic stem cells, researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have developed a new method to evaluate which mutations, or changes, in a gene known to increase breast cancer susceptibility, may lead to cancer. The new test, called a functional assay, is more comprehensive and reliable than most current methods. This new test could become a useful and viable tool for genetic counselors, and may have implications beyond cancer.

View Original Article Tue, 08 Jul 2008 12:00:00 PDT
The New York Times on Sunday examined how the Genentech cancer drug Avastin "signifies both the hopes and dilemmas of modern medicine" because while it offers incremental benefits for cancer patients, the drug is costly and concerns have been raised about its safety and efficacy.

View Original Article Tue, 08 Jul 2008 04:00:00 PDT
Scientists from Aberdeen, Luxembourg and the South Pacific have studied the properties of natural products derived from animals found in Fijian waters, and shown that not only may certain compounds have potential use in anti-cancer therapies, but others may also be useful for improving drug delivery, currently one of the most significant problems faced by medical researchers.

View Original Article Tue, 08 Jul 2008 04:00:00 PDT
We already know that recycling benefits our planet; and now new research suggests that the cellular version might be useful for battling cancer. Scientists at Stanford University have identified a molecule that uses this unexpected pathway to selectively kill cancer cells. The research, published by Cell Press in the July 8th issue of the journal Cancer Cell, may drive treatment strategies for cancer in an entirely new direction.

View Original Article Tue, 08 Jul 2008 04:00:00 PDT
Scientists have identified a new antitumor drug that might prove useful in developing treatments for multiple human cancers. The research, published by Cell Press in the July 8 issue of the journal Cancer Cell, advances the understanding of one of the most frequently disrupted tumor suppressor proteins in human cancer and provides new insight into the regulation of the complex process of cellular protein degradation under normal and pathological conditions.